Kleineidam and colleagues found that the P522R variant significantly reduced microglia phagocytosis of damaged but surviving neurons and synapses, and reduced pathological manifestations of Tau in the presence of Aβ, thereby reducing cognitive impairment in the course of AD. This evidence concerns the gene MAPT and Cognitive impairment.